In the PRO/CON session, we will discuss problems related to liver transplantation in obese patients as well as the use of coagulation factor concentrates during the transplant surgery.
When
Monday, September 13, 2021 · 10:55 a.m.
Paris (GMT +2:00)
WEBINAR ENDED
Agenda
LT with BMI above 45 can be performed without any limitations - Varvara Kirchner, MD, FACS
LT with BMI above 45 should not be performed - Choy Lewis, MD
Rebuttal
Clotting factor concentrates should not be used for the management of coagulopathies in liver transplantation - Miquel Lozano, MD, PhD
Clotting factor concentrates are safe and beneficial for the management of coagulopathies in liver transplantation - Ecaterina Scarlatescu, MD, PhD